Neurocrine Biosciences To Present At The 21st Annual Piper Jaffray Health Care Conference
Live audio webcast Tuesday, December 1, 2009
12:00PM 11/24/09
A Pullback Will Test the Market's Mettle (RealMoney.com $)
A successful test of the lows would be a very bullish development.
08:00AM 03/27/09
Neurocrine's Elagolix Misses Main Study Goal
Patients treated for endometriosis with elagolix reported improved daily pelvic pain scores compared with placebo, but the difference wasn't statistically significant.
01:21AM 03/26/09
Insider Buys $12.8 Million of Republic Services
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
08:52AM 01/27/09
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:18AM 01/23/09
Biotech Mailbag: Bad CEOs Offer Lessons
Senior Columnist Adam Feuerstein's selection of Kelly Martin as the worst biotech CEO for 2008 highlights the need for investors to scrutinize management teams before plunging into an investment.
11:08AM 12/19/08
Biotech Mailbag: Bad CEOs Offer Lessons (RealMoney.com $)
Senior Columnist Adam Feuerstein's selection of Kelly Martin as the worst biotech CEO for 2008 highlights the need for investors to scrutinize management teams before plunging into an investment.
07:01AM 12/19/08
Biotech Clinical Trials to Watch in 2009
Senior Writer Adam Feuerstein provides a list of biotech and drug clinical trials expected to move stocks in 2009.
10:04AM 12/18/08
A Compelling Opportunity (Biotech Select $)
This solid biotech name deserves more investor attention. Plus, a look ahead to some of 2009's clinical trials.
09:48AM 12/17/08
Biotech Stocks Swept Up by Rally (Biotech Select $)
However, keep in mind that these names tend to swing up into year-end and then fall in January.
10:12AM 12/10/08
Single Drugmakers Seek Rich Partners
Scores of smaller biotech firms have unpartnered drugs in the pipeline, making them ripe for alliances or takeovers.
09:55AM 12/08/08
Biotech Mailbag: Avoid Nuvelo-ARCA Merger
The centerpiece of the newly combined company is Gencaro, an unimpressive heart failure drug.
11:05AM 09/26/08
Biotech Mailbag: Avoid Nuvelo-ARCA Merger (RealMoney.com $)
The centerpiece of the newly combined company is Gencaro, an unimpressive heart failure drug.
07:07AM 09/26/08
Baxter International Hiding in Plain Sight
In the past five years, its stock has more than tripled, easily outperforming the S&P 500 and the Amex Index of large drug stocks. Is anyone paying attention?
06:59AM 07/01/08
Wedneday's Winners & Losers: Take-Two Takes Off
The video-game publisher shrinks its losses.
05:29PM 12/19/07
Connect with TheStreet